[1]林 峰,陈铃雄,刘 羽,等.不同踝下流出道病变程度糖尿病足患者接受膝下动脉球囊扩张的疗效及其影响因素[J].介入放射学杂志,2023,32(10):965-969.
 LIN Feng,CHEN Lingxiong,LIU Yu,et al.The therapeutic effect of subpatellar artery balloon dilatation for diabetic foot patients with different degrees of submalleolar outflow tract lesions and its influencing factors[J].journal interventional radiology,2023,32(10):965-969.
点击复制

不同踝下流出道病变程度糖尿病足患者接受膝下动脉球囊扩张的疗效及其影响因素()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年10
页码:
965-969
栏目:
血管介入
出版日期:
2023-10-31

文章信息/Info

Title:
The therapeutic effect of subpatellar artery balloon dilatation for diabetic foot patients with different degrees of submalleolar outflow tract lesions and its influencing factors
作者:
林 峰 陈铃雄 刘 羽 张旭明 尹志达
Author(s):
LIN Feng CHEN Lingxiong LIU Yu ZHANG Xuming YIN Zhida.
Department of Interventional Vascular Surgery, Affiliated Mindong Hospital of Fujian Medical University, Fu’an, Fujian Province 355000, China
关键词:
【关键词】 糖尿病足 膝下动脉闭塞下肢动脉硬化闭塞 动脉球囊扩张 全球肢体解剖分期系统
文献标志码:
A
摘要:
【摘要】 目的 探讨不同踝下流出道病变程度糖尿病足患者接受膝下动脉球囊扩张的疗效及其影响因素。方法 选择2020年10月至 2021年 10月福建医科大学附属闽东医院介入血管外科收治的糖尿病足患者153例。所有患者术前经全球肢体解剖分期系统(GLASS)评估踝下流出道病变程度,并依此将患者分为P0组34例,P1组61例,P2组58例。术后3、6、12个月电话随访和门诊复查,统计靶血管通畅率以及靶血管再狭窄发生情况。比较不同踝下流出道病变程度糖尿病足患者靶血管通畅率和再狭窄发生率差异,分析影响糖尿病足患者接受膝下动脉球囊扩张术后靶血管再狭窄的因素。结果 P0组术后3、6、12个月一期、二期靶血管通畅率高于P1组、P2组(P<0.017),P1组和P2组比较差异无统计学意义(P>0.017)。随访期间3组靶血管再狭窄率差异有统计学意义(χ2=12.330,P<0.05)。TASC Ⅱ分级D级、踝下流出道病变程度是糖尿病足患者接受膝下动脉球囊扩张术后靶血管再狭窄的危险因素(P<0.05),药物涂层球囊是保护因素(P<0.05)。结论 踝下流出道不良可能与糖尿病足患者接受膝下动脉球囊扩张治疗后靶血管再狭窄有关,改善踝下流出道可能有助于提高临床疗效。

参考文献/References:

[1] Wu Y, Shen Y, Sun H. Intelligent algorithm- based analysis on ultrasound image characteristics of patients with lower extremity arteriosclerosis occlusion and its correlation with diabetic mellitus foot[J]. J Healthc Eng, 2021, 2021: 7758206.
[2] 陈 懿,陆舜钦. 下肢动脉粥样硬化闭塞症患者C型凝集素样受体- 2水平与介入术后2年支架内再狭窄的关系[J]. 介入放射学杂志, 2021, 30:498- 501.
[3] Tepe G, Laird J, Schneider P, et al. Drug- coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12- month results from the IN.PACT SFA randomized trial[J]. Circulation, 2015, 131: 495- 502.
[4] 郭小勇,田艳霜,曹 庆,等. 糖尿病足合并下肢动脉粥样硬化闭塞症患者腔内介入治疗效果观察[J]. 中国医药, 2022, 17:1180- 1183.
[5] 高明杰,华 扬,赵新宇,等. 糖尿病患者膝下流出道病变程度与股腘动脉支架通畅率的相关性研究[J]. 中华超声影像学杂志, 2020, 29:153- 157.
[6] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13:315- 409.
[7] Haga M, Shindo S, Motohashi S, et al. Early evaluation of the infrainguinal revascularization strategy selection tool of the global vascular guidelines for chronic limb- threatening ischemia patients[J]. J Vasc Surg, 2021, 74: 1253- 1260.e2.
[8] 中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华普通外科学文献(电子版), 2016, 10:1- 18.
[9] 牛晓阳,王 兵,吴 斐,等. 复杂股腘动脉硬化闭塞症的杂交手术治疗[J]. 中国普通外科杂志, 2017, 26:722- 728.
[10] 王预立,倪其泓,杨硕菲,等. 紫杉醇药物球囊治疗股腘动脉硬化性闭塞症的早期临床结果分析[J].中华普通外科杂志,2021, 36:672- 676.
[11] Takahara M. Diabetes mellitus and lower extremity peripheral artery disease[J]. JMA J, 2021, 4: 225- 231.
[12] Jia S, Liu J, Sun G, et al. Drug- coated balloon angioplasty versus standard uncoated balloon angioplasty for long femoropopliteal lesions: post hoc analysis of the 24- month results of the Acoart I study[J]. Ann Vasc Surg, 2022, 82: 70- 80.
[13] 黄 伟,何春水,刘 洋,等. 膝下动脉通畅性对股腘动脉硬化闭塞性病变患者药物涂层球囊扩张术后一期通畅率的影响[J]. 血管与腔内血管外科杂志, 2022, 8:911- 916.
[14] Iida O, Takahara M, Soga Y, et al. Shared and differential factors influencing restenosis following endovascular therapy between TASC(Trans- Atlantic Inter- Society Consensus) Ⅱ class A to C and D lesions in the femoropopliteal artery[J]. JACC Cardiovasc Interv, 2014, 7: 792- 798.
[15] Li X, Wu L, Yang Z, et al. Assessment of microcirculation in the type 2 diabetic and impaired glucose tolerance feet of elderly men by CEUS[J]. Diabetes Metab Syndr Obes, 2021, 14: 3647- 3652.
[16] Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb- threatening ischemia[J]. Eur J Vasc Endovasc Surg, 2019, 58: S1- S109.
[17] Tokuda T, Oba Y, Koshida R, et al. Validation of Global Limb Anatomical Staging System(GLASS) in patients with hemodialysis and chronic limb- threatening ischemia after endovascular treatment[J]. Heart Vessels, 2021, 36: 809- 817.
[18] Liang P, Marcaccio CL, Darling JD, et al. Validation of the global limb anatomic staging system in first- time lower extremity revascularization[J]. J Vasc Surg, 2021, 73: 1683- 1691.e1.
[19] Tokuda T, Oba Y, Koshida R, et al. Prediction of the technical success of endovascular therapy in patients with critical limb threatening ischaemia using the global limb anatomical staging system[J]. Eur J Vasc Endovasc Surg, 2020, 60: 696- 702.
[20] Ding HX, Ma HF, Xing N, et al. Five- year follow- up observation of interventional therapy for lower extremity vascular disease in type 2 diabetes and analysis of risk factors for restenosis[J]. J Diabetes, 2021, 13: 134- 142.
[21] Bausback Y, Wittig T, Schmidt A, et al. Drug- eluting stent versus drug- coated balloon revascularization in patients with femoropopliteal arterial disease[J]. J Am Coll Cardiol, 2019, 73: 667- 679.

相似文献/References:

[1]国际血管联盟中国分会糖尿病足专业委员会.糖尿病足诊治指南[J].介入放射学杂志,2013,(09):705.
 Diabetic Foot Committee GU Yong? quan. Guideline on the diagnosis and treatment of diabetic foot China Branch of the International Union of Angiology[J].journal interventional radiology,2013,(10):705.
[2]王春梅,谷涌泉,李建新,等. 糖尿病足介入治疗围手术期处理[J].介入放射学杂志,2013,(09):780.
 WANG Chun? mei,GU Yong? quan,LI Jian? xin,et al. Perioperative management of interventional therapy for diabetic foot[J].journal interventional radiology,2013,(10):780.
[3]李 菁,王 珏. 糖尿病足的影像学研究进展[J].介入放射学杂志,2014,(05):456.
 LI Jing,WANG Jue.. Advances in imaging research of diabetic foot .[J].journal interventional radiology,2014,(10):456.
[4]马 旭,李跃华,王建波.糖尿病下肢血管病的血管内治疗进展[J].介入放射学杂志,2015,(11):1011.
 MA Xu,LI Yue- hua,WANG Jian- bo.Recent progress in endovascular treatment for diabetic lower extremity vascular disease[J].journal interventional radiology,2015,(10):1011.
[5]田红岸,余开湖,林凤平,等.自体干细胞介入治疗糖尿病足临床效果观察[J].介入放射学杂志,2016,(12):1040.
 TIAN Hong- an,YU Kai- hu,LIN Feng- ping,et al.PTA combined with transplantation of autologous bone marrow stem cells for diabetic foot: observation of clinical effect[J].journal interventional radiology,2016,(10):1040.
[6]杨硕菲,张 岚.膝下动脉闭塞腔内治疗热点问题——实践与思考[J].介入放射学杂志,2017,(06):481.
 YANG Shuofei,ZHANG Lan.Endovascular treatment of infrapopliteal artery occlusion: clinical practice and thinking of present hot issues[J].journal interventional radiology,2017,(10):481.
[7]中国糖尿病足细胞与介入治疗技术联盟,中国介入医师分会介入医学与生物工程 技术委员会,国家放射与治疗临床医学研究中心.糖尿病足介入综合诊治临床指南(第六版)[J].介入放射学杂志,2020,29(09):853.
 China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot,Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch,National Centre for Clinical Medical Research on Radiation and Treatment. LI Maoquan..Clinical guidelines for integrated diagnosis and treatment of diabetic foot(sixth edition)[J].journal interventional radiology,2020,29(10):853.

备注/Memo

备注/Memo:
(收稿日期:2022- 11- 30)
(本文编辑:新 宇)
更新日期/Last Update: 2023-10-31